Kurs
-2,17%
Kurs
-2,17%
Open
7,44
High
7,44
Low
7,16
Close
7,20
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
0,16 MNOK
Likviditet
0,16 MNOK
Rel. mcap
0,04%
Antal aktier
22 725
Likviditet under dagen för detta pressmeddelande
Kalender
Tid* | ||
2026-02-19 | 08:00 | Bokslutskommuniké 2025 |
2025-11-06 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-26 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-13 | N/A | Årsstämma |
2025-05-07 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-20 | 08:00 | Bokslutskommuniké 2024 |
2024-11-20 | - | Extra Bolagsstämma 2024 |
2024-11-07 | - | Kvartalsrapport 2024-Q3 |
2024-08-26 | - | Kvartalsrapport 2024-Q2 |
2024-05-15 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2024-05-14 | - | Årsstämma |
2024-05-08 | - | Kvartalsrapport 2024-Q1 |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-11-02 | - | X-dag halvårsutdelning CONTX 0.15741 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-08-24 | - | Kvartalsrapport 2023-Q2 |
2023-05-08 | - | X-dag halvårsutdelning CONTX 0.15741 |
2023-05-05 | - | X-dag halvårsutdelning CONTX 0.15645 |
2023-05-03 | - | Årsstämma |
2023-04-27 | - | Kvartalsrapport 2023-Q1 |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-10-20 | - | Kvartalsrapport 2022-Q3 |
2022-08-11 | - | Kvartalsrapport 2022-Q2 |
2022-05-05 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2022-05-04 | - | Årsstämma |
2022-04-21 | - | Kvartalsrapport 2022-Q1 |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-12-10 | - | Extra Bolagsstämma 2021 |
2021-10-21 | - | Kvartalsrapport 2021-Q3 |
2021-08-12 | - | Kvartalsrapport 2021-Q2 |
2021-05-06 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2021-05-05 | - | Årsstämma |
2021-04-22 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-08-19 | - | Split CONTX 1:10 |
2020-08-13 | - | Kvartalsrapport 2020-Q2 |
2020-08-05 | - | Extra Bolagsstämma 2020 |
2020-05-07 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2020-05-06 | - | Årsstämma |
2020-04-23 | - | Kvartalsrapport 2020-Q1 |
2020-02-20 | - | Bokslutskommuniké 2019 |
2019-10-24 | - | Kvartalsrapport 2019-Q3 |
2019-08-15 | - | Kvartalsrapport 2019-Q2 |
2019-05-09 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2019-05-08 | - | Årsstämma |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-02-21 | - | Bokslutskommuniké 2018 |
2018-10-25 | - | Kvartalsrapport 2018-Q3 |
2018-08-16 | - | Kvartalsrapport 2018-Q2 |
2018-05-11 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2018-05-09 | - | Årsstämma |
2018-04-26 | - | Kvartalsrapport 2018-Q1 |
2018-02-22 | - | Bokslutskommuniké 2017 |
2017-10-26 | - | Kvartalsrapport 2017-Q3 |
2017-08-17 | - | Kvartalsrapport 2017-Q2 |
2017-05-11 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2017-05-10 | - | Årsstämma |
2017-04-27 | - | Kvartalsrapport 2017-Q1 |
2017-02-23 | - | Bokslutskommuniké 2016 |
2016-10-27 | - | Kvartalsrapport 2016-Q3 |
2016-08-18 | - | Kvartalsrapport 2016-Q2 |
2016-04-21 | - | Kvartalsrapport 2016-Q1 |
2016-04-21 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2016-04-20 | - | Årsstämma |
2016-02-18 | - | Bokslutskommuniké 2015 |
2015-10-22 | - | Kvartalsrapport 2015-Q3 |
2015-08-20 | - | Kvartalsrapport 2015-Q2 |
2015-04-23 | - | Kvartalsrapport 2015-Q1 |
2015-04-23 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2015-04-22 | - | Årsstämma |
2015-02-19 | - | Bokslutskommuniké 2014 |
2014-10-23 | - | Kvartalsrapport 2014-Q3 |
2014-08-21 | - | Kvartalsrapport 2014-Q2 |
2014-05-12 | - | 15-7 2014 |
2014-04-24 | - | Kvartalsrapport 2014-Q1 |
2014-04-24 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2014-04-23 | - | Årsstämma |
2014-02-20 | - | Bokslutskommuniké 2013 |
2013-10-24 | - | Kvartalsrapport 2013-Q3 |
2013-08-22 | - | Kvartalsrapport 2013-Q2 |
2013-06-13 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2013-06-12 | - | Årsstämma |
2013-04-25 | - | Kvartalsrapport 2013-Q1 |
2013-02-21 | - | Bokslutskommuniké 2012 |
2012-10-25 | - | Kvartalsrapport 2012-Q3 |
2012-08-23 | - | Kvartalsrapport 2012-Q2 |
2012-06-14 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2012-06-13 | - | Årsstämma |
2012-04-26 | - | Kvartalsrapport 2012-Q1 |
2012-02-23 | - | Bokslutskommuniké 2011 |
2011-10-27 | - | Kvartalsrapport 2011-Q3 |
2011-08-25 | - | Kvartalsrapport 2011-Q2 |
2011-06-10 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2011-06-09 | - | Årsstämma |
2011-04-28 | - | Kvartalsrapport 2011-Q1 |
2011-02-17 | - | Bokslutskommuniké 2010 |
2010-10-21 | - | Kvartalsrapport 2010-Q3 |
2010-08-19 | - | Kvartalsrapport 2010-Q2 |
2010-06-04 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2010-06-03 | - | Årsstämma |
2010-04-21 | - | Kvartalsrapport 2010-Q1 |
2010-02-18 | - | Bokslutskommuniké 2009 |
2009-10-22 | - | Kvartalsrapport 2009-Q3 |
2009-08-20 | - | Kvartalsrapport 2009-Q2 |
2009-04-23 | - | Kvartalsrapport 2009-Q1 |
2008-06-06 | - | X-dag ordinarie utdelning CONTX 1.50 NOK |
Beskrivning
Land | Sverige |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Medicinteknik |
2023-11-20 15:58:27
STOCKHOLM, SWEDEN / November 21, 2023 / Ever since they started out in 1983 in
Linköping, Sweden, ContextVision's innovative solutions have time, and time
again set new standards in medical image enhancement. Forty years later, they
continue to break new ground, driven by the same untiring passion and innovative
thinking that have made them leaders within their field.
Taking AI and machine learning to whole new fields
When it comes to applying artificial intelligence (AI) and machine learning to
medical imaging, ContextVision has always been ahead of its field. Over the last
decades, the company's pioneering technologies have evolved into a highly
sophisticated portfolio of solutions for Ultrasound's, X-ray's, MRI's, and more.
Altumira - now even more powerful
One of the company's most successful solutions is Altumira, a powerful software
that draws on advanced AI to take X-ray images to a whole new level. This year's
RSNA sees the unveiling of Altumira's new, impressive scatter correction
functionality, allowing for exceptional quality in images acquired without a
physical grid. In addition, Altumira Plus - for dynamic imaging - will be
upgraded with improved noise suppression and enhanced visualization of details,
e.g., stents and vessels.
Transforming the future of healthcare
Today, ContextVision operates on a global scale, serving healthcare institutions
and professionals around the world. While innovation has always been a strong
driving force, so has a genuine concern for the overall transformation of
healthcare.
"By continuously staying ahead of technological advancements, we can not only
improve the quality of medical imaging, but also help transform patient care all
over the world," says Gerald Pötzsch, CEO of ContextVision.
Join ContextVision at RSNA
At RSNA 2023, ContextVision will be celebrating its 40th anniversary and
demonstrating its latest innovations, including the new Altumira features. Join
them at Booth #6802. For more info, contact Gerald Pötzsch, CEO at
gerald.potzsch@contextvision.com or visit www.contextvision.com.
About ContextVision
ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound, X
-ray and MRI equipment around the world. Our expertise is to develop powerful
software products, based on proprietary technology and artificial intelligence
for image-based applications. The company's cutting-edge technology helps
clinicians accurately interpret medical images, a crucial foundation for better
diagnosis and treatment. The company, established in 1983, is based in Sweden
with local representation in the U.S., Japan, China, and Korea. ContextVision is
listed on the Oslo Stock Exchange under the ticker CONTX.